Hematology-Oncology
Lim, Ho Yeong
95 AppointmentProfessor
Speciality Interests
Schedule
05 | MON 20 |
TUE 21 |
WEN 22 |
THU 23 |
FRI 24 |
---|---|---|---|---|---|
AM | available | ||||
PM | available |
Medical School
1998~2001 Ph.D. in Medicine Department of Pathology, Korea University College of Medicine, Seoul, Korea Awarded Ph.D. degree in Medicine 1978~1984 Master of Science Department of Medicine, Yonsei University College of Medicine, Seoul, Korea Awarded M.D. degree in Medicine
Specialty Training
Fellowship | Yonsei Cancer Center, Yonsei University Severance Hospital | |
---|---|---|
Residency | 1985~1988 Yonsei University Severance Hospital | |
Internship | 1984~1985 Yonsei University Medical Center, Seoul, Korea |
Other Education
2010~2011 Director Strategic Business Development Office of strategy & Planning Samsung Healthcare Group
2009~2011 Head Division of Hematology-Oncology, Department of Medicine Samsung Medical Center
2007~2010 Executive Director Samsung Clinical Research Institute
2006~present Professor Division of Hematology-Oncology, Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea
2003~2006 Director Clinical Research Center, Ajou University School of Medicine Suwon, Korea
2001~2006 Chairman Department of Hematology-Oncology, Ajou University School of Medicine Suwon, Korea
2004~2006 Professor Department of Hematology-Oncology, Ajou University School of Medicine
2000~2004 Associate Professor Department of Hematology-Oncology, Ajou University School of Medicine Suwon, Korea
1995~1997 Postdoctoral fellow Johns Hopkins University Oncology Center, Brady Urological Institute Baltimore, MD, U.S.A.
1995~2000 Assistant Professor Department of Hematology-Oncology, Ajou University School of Medicine Suwon, Korea
1993~1995 Instructor Department of Hematology-Oncology, Ajou University School of Medicine Suwon, Korea
1991~1993 Research Instructor Oncology Division, Yonsei Cancer Center, Department of Internal medicine, Yonsei University College of Medicine Seoul, Korea
Participation in Academic Societies
and Research
Member Korean Association for Clinical Oncology
Member Korean Cancer Association
Member Korean Association of Internal Medicine
Member Korean Medical Association
Member Korean Cancer Study Group
Active member AACR (American Association of Cancer Research)
Active member ASCO (American Society of Clinical Oncology)
Thesis
BRIT J CANCER 2021 10.1038/s41416-021-01380-3
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
ADV THER 2021 10.1007/s12325-021-01700-2
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein >= 400 ng/mL: A Matching-Adjusted Indirect Comparison
LIVER CANCER 2021 10.1159/000515553
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial
EUR UROL 2021 10.1016/j.eururo.2020.12.029
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial
ANN ONCOL 2021 10.1016/j.annonc.2020.11.017
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial